Loading organizations...
Loading organizations...
Allos: Causal AI solutions developer for precision medicine, transforming complex drugs and powering co-pilots for medical professionals.
Allos is an Oxford, United Kingdom-based healthcare technology company that develops an explainable causal artificial intelligence co-pilot designed specifically to assist medical professionals with precision medicine and complex clinical workflows. The proprietary software platform identifies true cause-and-effect relationships within large volumes of medical data to provide transparent, understandable reasoning for applications across next-generation clinical trials, hospital management, radiology, and pharmaceutical development. Furthermore, the organization's computational technology is actively utilized to transform existing complex drugs into safer, highly bioavailable, and easier-to-administer medicines for diverse patient populations. The enterprise is currently backed by a syndicate of five institutional investors, having successfully secured early-stage venture funding from recognizable financial entities including Habico Invest and Oxford University Innovation. Allos was officially founded in 2022 by the executive leadership team of Aditya Varna Iyer, Isaac To, and Ivano Lodato.
Allos has raised $5.0M across 1 funding round.
Allos has raised $5.0M in total across 1 funding round.
Allos has raised $5.0M in total across 1 funding round.
Allos's investors include Joel Schoppig, Habico Invest, University of California.
Allos has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 12, 2026 | $5.0M Seed | Joel Schoppig | Habico Invest, University of California |